Mind Medicine Australia Formally Challenges TGA Interim Decision on Psilocybine – Assisted Therapy for End – of – Life Distress
Mind Medicine Australia, June 3, 2026
On 29 May 2026, the TGA’s Delegate issued an Interim Decision refusing the joint application by Mind Medicine Australia and palliative care group EndWise to extend the Schedule 8 scheduling of psilocybine for use in psychotherapy for patients experiencing existential distress at the end of life.
We have reviewed the decision in full. It does not hold.
New show announced – Dr Bessel van der Kolk 2026 Australian Workshop Tour – Selling fast! The Body Keeps the Score: Brain, Mind & Body in the Healing of Trauma in Turbulent Times
Mind Medicine Australia, March 11, 2026
World-renowned psychiatrist and global trauma expert Bessel van der Kolk, author of the global bestseller The Body Keeps the Score, will return to Australia in April 2026, with events in Sydney, Brisbane, Adelaide, and Melbourne on April 12, 16, 19, 25, and 26 for a national workshop tour.
Mind Medicine Australia: Seven Years of Transforming Mental Health in Australia
Mind Medicine Australia, February 10, 2026
Seven years ago, psychedelic-assisted therapies were not part of Australia’s mental health system. The first early-stage clinical trial in Australia hadn’t yet started recruitment and MDMA and psilocybin were both prohibited substances. Today, Australia is leading the World in the clinical rollout of these therapies.
Dr Bessel van der Kolk Announces 2026 Australian Workshop Tour
Mind Medicine Australia, December 17, 2025
World-renowned psychiatrist and trauma expert Dr Bessel van der Kolk, author of the global bestseller The Body Keeps the Score, will return to Australia in April 2026 for a four-city national workshop tour. He will be joined by acclaimed trauma educator Licia Sky, with special guest performer Tania de Jong AM, presented by Activate Media Events in partnership with the charity Mind Medicine Australia.
Psychedelic-Assisted Therapies Being Delivered Across Australia with Unparalleled Results
Mind Medicine Australia, November 27, 2025
Mind Medicine Australia (MMA) is proud to share an important update on the current state of play regarding the national rollout of psychedelic-assisted therapies.
Australia leads the way with the expansion of psychedelic-assisted therapies, supported by the Mind Medicine Australia Clinic and Centre of Excellence
Mind Medicine Australia, September 3, 2025
The Mind Medicine Australia Clinic (MMAC) represents an important step forward in MMA’s strategy to integrate psychedelic-assisted therapies into Australia’s mental healthcare system.
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
Newsfile, September 3, 2025
Export of 1,000 natural psilocybin capsules for prescription use under Australia’s Authorised Prescriber Scheme follows the Company’s successful launch of MDMA sales in 2024. Mind Medicine Australia, Optimi’s authorized commercial partner, will oversee distribution and patient coordination through Australia’s network of clinics and hospitals.
Psychedelic-Assisted Therapies and How Australia is Leading the World Right Now
Mind Medicine Australia, April 27, 2025
Mind Medicine Australia (MMA) is proud to share an important update on the ground-breaking work that we are doing to develop safe access to psychedelic-assisted therapies for mental illness sufferers in Australia.
Mind Medicine Australia & Palliative Care PAT Coalition
Mind Medicine Australia, March 16, 2025
An application to the TGA has been submitted to allow patients approaching the end of their lives to access psilocybin-assisted therapy.
Two Year Anniversary – When Australia Made History Private citizens are stepping in to ensure equitable access to innovative treatments for mental illness and it’s changing lives.
Mind Medicine Australia, February 3, 2025
February 3rd marks two years since the TGA announced that Australia would be the first country in the world to allow access to MDMA and psilocybin as controlled medicines, when used as a part of therapy. Early outcomes look very promising and there have been no significant adverse events reported. With PAT now accessible in Australia, MMA is working on challenges associated with the clinical roll out.
New South Wales Amends State Regulations to Expand Access to Psychedelic-Assisted Therapies
Mind Medicine Australia, December 16, 2024
On Friday, 13 December 2024, NSW Health announced updates to State regulations governing the delivery of psychedelic-assisted therapies (PAT). The new regulations now align with other states, by allowing PAT to be delivered in psychiatric clinics and other appropriate clinical settings. The amendment follows extensive advocacy by Mind Medicine Australia (MMA).
Mind Medicine Australia & Drug Science Collaborate to Teach the Fundamentals of Psychedelic-Assisted Therapies to International Audiences
Mind Medicine Australia, August 1, 2024
Mind Medicine Australia (MMA) is excited to announce our collaboration with Drug Science to update our popular Fundamentals of Psychedelic-Assisted Therapies training programme for an international cohort.
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules
Globe News Wire, May 29, 2024
Company preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.
Andrew Robb Backs Campaign For Realistic Access To Psychedelic Therapies In NSW
Mind Medicine Australia, March 13, 2024
Given the mental health crisis facing Australia, the former Federal Coalition Minister, Andrew Robb, today called on all NSW State Parliamentarians to demand urgent amendments to NSW Health Department regulations.
Mind Medicine Australia, Marks 5-Year Milestone with Global Achievements in Psychedelic Therapies
Mind Medicine Australia, February 12, 2024
Mind Medicine Australia (MMA), a trailblazing charitable organisation in mental health advocacy and innovation, proudly celebrates its 5th Anniversary this week. Over the past five years, MMA has been at the forefront of transformative progress in the field of psychedelic-assisted therapies in Australia and internationally.
Psychiatrists give the First Psychedelic Medicine Dosing Sessions in Clinical Settings in 50 Years this Week in Melbourne Australia
Mind Medicine Australia, January 19, 2024
This week the first two patients received treatment with psychedelic-assisted therapies as part of the Therapeutic Goods Administration’s (TGA) Authorised Prescriber (AP) program in Melbourne, Australia with medicines and training supplied through Mind Medicine Australia.
World Renowned Dr Ben Sessa (UK) to visit Australia in October 2023 to lead training and education for Psychedelic-Assisted Therapies
Mind Medicine Australia, October 18, 2023
Mind Medicine Australia (MMA) is delighted to bring leading psychedelic researchers Dr Ben Sessa (Bristol, UK) and Dr Lauren Macdonald (London, UK) to Australia this October and November to lead the residential training for MMA’s leading Certificate in Psychedelic-Assisted Therapies (CPAT) program.
New Overseas Trial Results Strongly Support the TGA’s Decision to Reschedule the controlled Use of MDMA and Psilocybin for Mental Illness
Mind Medicine Australia, September 26, 2023
On 3rd February 2023 the TGA announced the restricted rescheduling of MDMA and Psilocybin as Schedule 8 Controlled Medicines when used as part of therapy for patients with post-traumatic stress disorder (MDMA) or treatment resistant Depression (psilocybin). As part of the decision the TGA acknowledged the current lack of treatment options for patients suffering from these mental illnesses which can cause immense suffering. It is therefore highly relevant that two major trials, which have just published their results in leading medical journals, provide further support for the use of these medicines in the controlled conditions envisaged by the TGA.
Psychedelic-Assisted Therapies are about to be available in Australia. What Does This Mean for Australia’s Mental Healthcare System?
Mind Medicine Australia, June 26, 2023
In just a few days psychiatrists will be able to apply to become Authorised Prescribers of MDMA and psilocybin. Authorised Prescribers will be able to prescribe these substances as part of therapy, in controlled clinical settings for patients with treatment-resistant depression (psilocybin) and treatment resistant post-traumatic stress disorder (MDMA).
The Enormous “Elephant in the Room” in assessing the Government’s Budget Announcement of a $2.3 billion increase to Mental Health Funding
Mind Medicine Australia, May 13, 2023
Mind Medicine Australia (MMA) welcomes the Government’s commitment to mental health and its drive to improve the mental health of Australians and reduce suicide rates. The increased funding for the sector announced in the Budget is an especially important part of this.